ERCC1 and breast cancer: In conclusion, BRCA1 (Pro871Leu), ERCC1 (Asn118Asn), CYP1B1 (Leu432Val), and SLCO1B3 (rs11045585) are associated with response to NCT in our cohort of breast cancer patients.